MRAK052686

From LncRNAWiki
Revision as of 06:06, 6 November 2018 by Huma (talk | contribs) (Created page with " ==Annotation== ===Name=== MRAK052686 ===Alias=== NA ===Disease=== Disease: nonalcoholic fatty liver disease [http://www.ncbi.nlm.nih.gov/pubmed/25623289 (PMID:25623289)]...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search



Annotation

Name

MRAK052686

Alias

NA

Disease

Disease: nonalcoholic fatty liver disease (PMID:25623289)

Dysfunction type: NA

Description: Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles. MRAK052686, was found strongly correlated with the antioxidant factor Nrf2, and both genes were down-regulated by the steatotic liver. The reduced expression of MRAK052686 and Nrf2 was completely reversed by BBR treatment, suggesting a new mechanism accounting for the therapeutic effect of BBR.


Function

Function Mechanism: NA (PMID:25623289)

Biological Process: pathogenic process

Description: therapy target